Body Composition Tracking on GLP-1: Tools Compared

Body composition tracking on a GLP-1 means measuring fat mass and lean mass separately instead of trusting a single scale weight, because the scale cannot tell you whether the pounds leaving are fat or hard-won muscle. The practical setup pairs one accurate periodic measurement (ideally a DEXA scan) with one consistent frequent reading (a smart scale or InBody), logged in an app that also tracks your protein and training so the numbers connect. Accuracy matters, but consistency and trend direction matter more.

This guide covers the measurement methods, the apps that surface body-composition data, and how to build a system that actually answers the only question that matters: am I losing fat or muscle?

Why body composition, not bodyweight

On a GLP-1 medication like Ozempic or Wegovy (semaglutide) or Zepbound or Mounjaro (tirzepatide), weight comes off fast, and not all of it is fat. Research suggests roughly 25 to 40 percent of the weight lost on these drugs can come from lean mass, with tirzepatide trials nearer 25 percent (the SURMOUNT-1 DEXA substudy) and some semaglutide trials near 40 percent (SUSTAIN 8 and the STEP 1 DEXA analysis).

"Lean mass" is everything that is not fat (muscle, water, organs, bone), so it is not identical to skeletal muscle, but a meaningful share of it is. A scale showing "down 12 pounds" cannot tell you if that was 12 pounds of fat or 8 pounds of fat and 4 of muscle. Body composition tracking is how you find out, and it is the difference between losing weight and losing the right weight. For the deeper "how do I tell" breakdown, see fat loss vs muscle loss on GLP-1.

There is a nuance worth holding onto, because it is easy to over-worry. In nearly all GLP-1 trials, absolute lean mass falls, but the ratio of lean to fat actually improves: you end up relatively leaner even though the lean-mass number dropped. The SEMALEAN real-world cohort is a good example, with the share of people meeting criteria for sarcopenic obesity falling from 49 percent to 33 percent over a year and handgrip strength improving. The goal of tracking is not zero lean-mass change; it is making sure fat is doing most of the leaving and muscle is being defended.

The measurement methods, briefly

Body composition tracking starts with how you capture the data. The five common methods, from most to least accurate, are DEXA, multi-frequency BIA (InBody), single-frequency BIA (smart scales), tape measurements, and strength benchmarks. Each has a place; the trade-off is always accuracy versus cost and convenience.

• DEXA scan (dual-energy X-ray absorptiometry): the gold standard, used in the major trials, with body-fat error research puts around 1 to 2 percentage points. Costs about $40 to $150 per scan and requires a facility visit, so it is periodic.
• InBody / multi-frequency BIA (bioelectrical impedance analysis): sends a small current through your body to estimate fat and lean mass; research suggests it can differ from DEXA by roughly 5 to 8 percentage points. Often free at gyms and good for trends.
• Smart scales (single-frequency BIA): the least accurate, with error often around 3 to 8 percentage points, but cheap and usable daily for trends.
• Tape measurements: free, no fat-versus-lean split, but circumference patterns hint at what is changing.
• Strength benchmarks: a free proxy for muscle function; falling strength while weight drops is a clear warning.

The full method-by-method comparison, including how often to use each, lives in how to track muscle loss on a GLP-1. This article focuses on what happens after you have a measurement: how apps surface and trend it.

What body-comp data an app should surface

A measurement device gives you a number on a given day. An app's job is to turn a series of those numbers into a story: is fat trending down while lean mass holds? The features that make an app useful for body composition on a GLP-1 are:

• Separate fat-mass and lean-mass trends, not just total weight.
• Body-fat percentage tracked over time.
• The ability to import or sync data from your measurement method (DEXA PDF, InBody, smart scale, or Apple Health).
• Protein and training data in the same place, since those are the levers that change the fat-to-muscle ratio.
• Some form of trend interpretation, so you are not left squinting at raw dots.

That last point is where most apps fall short. Plenty of tools will let you type in a body-fat number; far fewer will tell you what the trend means or flag when lean mass is sliding.

There is a meaningful difference between an app that logs a number and one that interprets it. Logging means you can store your body-fat percentage and see it on a chart. Interpreting means the app actively trends lean mass against the things that move it (protein and training), imports your DEXA or InBody data so a clinical measurement feeds the same timeline, and surfaces a warning when the direction turns concerning. For a GLP-1 user, the interpretive layer is the point: the raw numbers are only as useful as your ability to read them in context, and most people do not have the time or the spreadsheet skills to do that by hand.

Methods and apps compared

Here is how the common measurement methods and a representative set of tracking tools compare on what body-composition data they surface and how they trend it. App facts are as of 2026 and can change, so check current listings before deciding; the point here is the category, not a feature scorecard. Accuracy figures are approximate and drawn from the body-composition measurement literature.

Tool or method	Body-comp data it surfaces	How it trends it
DEXA scan	Fat mass, lean mass, bone, regional breakdown; about 1 to 2 pt error	You compare PDFs scan over scan manually
InBody / multi-frequency BIA	Fat and lean mass, segmental; about 5 to 8 pt vs DEXA	Some machines store history; otherwise you log it yourself
Smart scale (single-frequency BIA)	Body-fat %, lean mass estimate; about 3 to 8 pt vs DEXA	App syncs daily readings into a trend line
Generic macro apps (e.g. MyFitnessPal)	Bodyweight, protein/macros; lean mass generally not a focus	Weight and macro trends; no fat-vs-muscle analysis
Shotsy	Can log body fat, lean mass, waist (recently added)	Logs and charts the numbers you enter
Phaze	DEXA import plus AI photo body-fat/muscle estimate (Beta), lean-mass trending	Trends imported and estimated body comp
Myo	Fat-vs-muscle split, body-fat %, syncs smart scale/DEXA/InBody	Trends lean mass vs protein and training, with a muscle-loss trend flag

A few honest notes. Generic macro apps are excellent at protein and calories but were not built to separate fat from muscle, which is the gap for GLP-1 users. Shotsy can now log body-fat and lean-mass numbers and has a large, polished community, though it logs those figures rather than running a dedicated muscle-loss analysis. Phaze is the closest peer on body composition specifically, with DEXA import and AI estimates, although resistance-training logging is not listed on it. For a full, fair head-to-head, see the best apps to track GLP-1 and muscle loss.

The reason this category matters at all is that body composition is only half the equation. Two numbers (fat mass and lean mass) tell you what happened; they do not tell you why, or what to change. The "why" lives in your protein intake and your training, which is exactly why an app that keeps body composition in a separate silo from your food and workout logs leaves you guessing. A 2025 study found fewer than half of GLP-1 users hit the minimum recommended protein target of about 1.2 g/kg/day, so for most people, a sliding lean-mass trend traces straight back to protein, if the data is in one place to see it.

Pick one method and one app, then don't switch

The single biggest mistake in body composition tracking is changing tools mid-stream. Every method uses different math, so a DEXA body-fat reading and a smart-scale reading are not directly comparable, and switching apps resets your trend. The system only works if it is consistent.

So commit to a setup and run it:

1. Choose one accurate method as your anchor (DEXA every 8 to 12 weeks, or a consistent InBody).
2. Choose one convenient method for between-scan trends (a smart scale used every morning, fasted).
3. Log both in a single app so fat and lean mass trend together over time.
4. Standardize conditions ruthlessly. Same time of day, same hydration, same device.

Do this for three months and you will have something the scale could never give you: a clear answer about whether your weight loss is the kind worth keeping.

How often should you measure? Match the cadence to the tool. An accurate method like DEXA needs 8 to 12 weeks between readings so real change can rise above the scan's normal variation; measuring it monthly mostly captures noise and cost. A trend tool like a smart scale can be used as often as daily, because the value comes from averaging many consistent readings into a smooth line, not from any single morning. Mismatch the two (a DEXA every two weeks, or a smart scale once a quarter) and you waste the strengths of both.

Where Myo fits

This is Myo's home turf. It is purpose-built to track fat versus lean mass next to protein and resistance training, the exact combination generic trackers leave out. You sync a smart scale, DEXA, or InBody, and Myo charts your lean-mass trend against your protein intake and your logged training sessions, with a muscle-loss trend flag designed to catch a worrying direction early. To be clear about what it is: Myo trends the data you bring in; it is not itself a measuring device, so the accuracy still comes from your chosen method.

The free tier covers one medication with weight, side effects, manual protein and fiber and water rings, and Apple Health sync. The fat-versus-muscle body-composition tracking, the trend flag, and the resistance-training logging with protein coaching are Premium ($6.99/mo, $39.99/yr with a 7-day trial, or $99.99 lifetime). Whether you use Myo or another tool, the principle is the same: track body composition, not just bodyweight, or you are flying blind on the question that decides whether your results last.

References

• Tirzepatide SURMOUNT-1 DEXA substudy, Diabetes, Obesity and Metabolism, 2025 (doi:10.1111/dom.16275).
• Semaglutide SUSTAIN 8, Diabetes, Obesity and Metabolism, 2020 (PMC6997246).
• Semaglutide STEP 1 DXA analysis, Journal of the Endocrine Society, 2021; Wilding et al., NEJM.
• Body-composition measurement method comparisons (DEXA, BIA, smart scales): ScienceDirect S2667268526000409; PMC8122302; Highland Longevity DEXA vs InBody.
• App features as of 2026 from official listings (Myo/PixelPort LLC, Phaze, Shotsy); verify current listings as features change.